Bayer fined $16.2M in price-fixing probe

Bayer was fined $16.2 million for fixing the prices of aspirin and other over-the-counter meds in Germany; the government alleged that a local Bayer subsidiary made illegal rebate deals with more than 21,000 pharmacies. Bayer denied the allegations, saying it agreed to the fine to avoid a long legal fight. Report

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.